MedPath

Janssens Wim

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:2

Trial Phases

1 Phases

Phase 3:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 3
3 (100.0%)

The CATALINA Study

Recruiting
Conditions
Chronic Obstructive Pulmonary Disease Exacerbation
First Posted Date
2021-08-17
Last Posted Date
2024-11-15
Lead Sponsor
Wim Janssens
Target Recruit Count
1000
Registration Number
NCT05008081
Locations
🇦🇹

Kepler University Hospital, Linz, Austria

🇧🇪

CHU St-Pierre Brussels, Brussels, Belgium

🇧🇪

UZ Leuven, Leuven, Belgium

and more 15 locations

Detection of Aspergillus Fumigatus and Sensitization in COPD Patients With Bronchiectasis vs Without Bronchiectasis

Conditions
Chronic Obstructive Pulmonary Disease
First Posted Date
2015-01-06
Last Posted Date
2015-08-24
Lead Sponsor
Wim Janssens
Target Recruit Count
100
Registration Number
NCT02332122
Locations
🇧🇪

UZ Gasthuisberg, Leuven, Vlaanderen, Belgium

BACE Trial Substudy 2 - FarmEc Substudy

Phase 3
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Drug: Placebo
First Posted Date
2014-07-31
Last Posted Date
2020-04-08
Lead Sponsor
Wim Janssens
Target Recruit Count
350
Registration Number
NCT02205255
Locations
🇧🇪

UZ Brussel, Brussel, Brussel Hoofdstedelijk Gewest, Belgium

🇧🇪

St. Pieterziekenhuis, Brussel, Brussels Hoofdstedelijk Gewest, Belgium

🇧🇪

ZNA Middelheim, Antwerpen, Vlaanderen, Belgium

and more 17 locations

BACE Trial Substudy 1 - PROactive Substudy

Phase 3
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Device: Dynaport®
Drug: Placebo
First Posted Date
2014-07-31
Last Posted Date
2020-04-08
Lead Sponsor
Wim Janssens
Target Recruit Count
60
Registration Number
NCT02205242
Locations
🇧🇪

St. Pieterziekenhuis, Brussel, Brussels Hoofdstedelijk Gewest, Belgium

🇧🇪

ZNA Middelheim, Antwerpen, Vlaanderen, Belgium

🇧🇪

Imelda Ziekenhuis, Bonheiden, Vlaanderen, Belgium

and more 3 locations

Azithromycin for Acute Exacerbations Requiring Hospitalization

Phase 3
Terminated
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Drug: Placebo
First Posted Date
2014-05-09
Last Posted Date
2018-09-05
Lead Sponsor
Wim Janssens
Target Recruit Count
301
Registration Number
NCT02135354
Locations
🇧🇪

UZ Brussel, Brussel, Brussel Hoofdstedelijk Gewest, Belgium

🇧🇪

St. Pieterziekenhuis, Brussel, Brussels Hoofdstedelijk Gewest, Belgium

🇧🇪

ZNA Middelheim, Antwerpen, Vlaanderen, Belgium

and more 17 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.